These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1847428)
21. Non-classical antifolates, 5-(N-phenylpyrrolidin-3-yl)-2,4,6-triaminopyrimidines and 2,4-Diamino-6(5H)-oxopyrimidines, synthesis and antitumor studies. Huang YL; Lin CF; Lee YJ; Li WW; Chao TC; Bacherikov VA; Chen KT; Chen CM; Su TL Bioorg Med Chem; 2003 Jan; 11(1):145-57. PubMed ID: 12467717 [TBL] [Abstract][Full Text] [Related]
22. Non-glutamate type pyrrolo[2,3-d]pyrimidine antifolates. I: Synthesis and biological properties of pyrrolo[2,3-d]pyrimidine antifolates containing tetrazole congener of glutamic acid. Itoh F; Yukishige K; Wajima M; Ootsu K; Akimoto H Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):230-5. PubMed ID: 7728929 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, biological, and antitumor activity of a highly potent 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitor with proton-coupled folate transporter and folate receptor selectivity over the reduced folate carrier that inhibits β-glycinamide ribonucleotide formyltransferase. Wang L; Desmoulin SK; Cherian C; Polin L; White K; Kushner J; Fulterer A; Chang MH; Mitchell-Ryan S; Stout M; Romero MF; Hou Z; Matherly LH; Gangjee A J Med Chem; 2011 Oct; 54(20):7150-64. PubMed ID: 21879757 [TBL] [Abstract][Full Text] [Related]
24. 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors. Wang L; Wallace A; Raghavan S; Deis SM; Wilson MR; Yang S; Polin L; White K; Kushner J; Orr S; George C; O'Connor C; Hou Z; Mitchell-Ryan S; Dann CE; Matherly LH; Gangjee A J Med Chem; 2015 Sep; 58(17):6938-59. PubMed ID: 26317331 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents. Tian C; Wang M; Han Z; Fang F; Zhang Z; Wang X; Liu J Eur J Med Chem; 2017 Sep; 138():630-643. PubMed ID: 28711701 [TBL] [Abstract][Full Text] [Related]
26. Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase. Xing R; Zhang H; Yuan J; Zhang K; Li L; Guo H; Zhao L; Zhang C; Li S; Gao T; Liu Y; Wang L Eur J Med Chem; 2017 Oct; 139():531-541. PubMed ID: 28830032 [TBL] [Abstract][Full Text] [Related]
27. Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis. Golani LK; Wallace-Povirk A; Deis SM; Wong J; Ke J; Gu X; Raghavan S; Wilson MR; Li X; Polin L; de Waal PW; White K; Kushner J; O'Connor C; Hou Z; Xu HE; Melcher K; Dann CE; Matherly LH; Gangjee A J Med Chem; 2016 Sep; 59(17):7856-76. PubMed ID: 27458733 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of TS and AICARFTase and as potential antitumor agents. Liu Y; Li M; Zhang H; Yuan J; Zhang C; Zhang K; Guo H; Zhao L; Du Y; Wang L; Ren L Eur J Med Chem; 2016 Jun; 115():245-56. PubMed ID: 27017552 [TBL] [Abstract][Full Text] [Related]
29. Targeting Nonsquamous Nonsmall Cell Lung Cancer via the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]Pyrimidine Thienoyl Antifolates. Wilson MR; Hou Z; Yang S; Polin L; Kushner J; White K; Huang J; Ratnam M; Gangjee A; Matherly LH Mol Pharmacol; 2016 Apr; 89(4):425-34. PubMed ID: 26837243 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activity of N(4)-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents. Gangjee A; Kurup S; Ihnat MA; Thorpe JE; Shenoy SS Bioorg Med Chem; 2010 May; 18(10):3575-87. PubMed ID: 20403700 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiproliferative activity of 2,4-disubstituted 6-aryl-7H-pyrrolo[3,2-d]pyrimidin-7-one 5-oxides. Pudziuvelyte E; Ríos-Luci C; León LG; Cikotiene I; Padrón JM Bioorg Med Chem; 2009 Jul; 17(14):4955-60. PubMed ID: 19527934 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, antiproliferative, and antiviral activity of certain 4-substituted and 4,5-disubstituted 7-[(1,3-dihydroxy-2-propoxy)methyl]pyrrolo[2,3-d]pyrimidines. Pudlo JS; Nassiri MR; Kern ER; Wotring LL; Drach JC; Townsend LB J Med Chem; 1990 Jul; 33(7):1984-92. PubMed ID: 2163454 [TBL] [Abstract][Full Text] [Related]
33. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases. Gangjee A; Vasudevan A; Queener SF; Kisliuk RL J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474 [TBL] [Abstract][Full Text] [Related]
34. Novel synthesis, properties, and NAD+-NADH type redox ability of 1,3-dimethylcyclohepta[4,5]pyrrolo[2,3-d]pyrimidine- 2,4(1,3h)-dionylium ions annulated with additional pyrrolo[2,3-d]pyrimidine-1,3(2,4h)-dione and furan analogue, and their hydride adducts. Naya S; Nishimura J; Nitta M J Org Chem; 2005 Nov; 70(24):9780-8. PubMed ID: 16292806 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and antifolate activity of 5-methyl-5,10-dideaza analogues of aminopterin and folic acid and an alternative synthesis of 5,10-dideazatetrahydrofolic acid, a potent inhibitor of glycinamide ribonucleotide formyltransferase. Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Thorndike J; Sirotnak FM J Med Chem; 1988 Nov; 31(11):2164-9. PubMed ID: 3184124 [TBL] [Abstract][Full Text] [Related]
36. 6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents. Gangjee A; Zhu Y; Queener SF J Med Chem; 1998 Nov; 41(23):4533-41. PubMed ID: 9804692 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line. Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963 [TBL] [Abstract][Full Text] [Related]
38. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents. Robson C; Meek MA; Grunwaldt JD; Lambert PA; Queener SF; Schmidt D; Griffin RJ J Med Chem; 1997 Sep; 40(19):3040-8. PubMed ID: 9301666 [TBL] [Abstract][Full Text] [Related]
39. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines. Gangjee A; Adair O; Queener SF J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486 [TBL] [Abstract][Full Text] [Related]
40. A new and efficient synthesis of pyrrolo[2,3-d]pyrimidine anticancer agents: Alimta (LY231514, MTA), homo-Alimta, TNP-351, and some aryl 5-substituted pyrrolo[2,3-d]pyrimidines. Taylor EC; Liu B J Org Chem; 2003 Dec; 68(26):9938-47. PubMed ID: 14682686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]